Beta Bionics, Inc. (BBNX) stock
BBNXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 11/304% below fair value
$14.33−0.39 (-2.65%)
Close on Nov 18, 2026Market cap $779.08MP/E –Yield –
Beta Bionics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
No total debt figures for Beta Bionics
Beta Bionics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?